Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

udenafil MeSH Supplementary Concept Data 2025


MeSH Supplementary
udenafil
Unique ID
C419664
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C419664
Entry Term(s)
3-(1-Methyl-7-oxo-3-propyl-4,7-dihydro-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-N-(2-(1-methyl-2-pyrrolidinyl)ethyl)-4-propoxybenzenesulfonamide
5-(2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one
DA 8159
DA-8159
Zidena
Pharm Action
Phosphodiesterase 5 Inhibitors
Registry Numbers
L5IB4XLY36
0
Related Numbers
268203-93-6
Previous Indexing
PHOSPHODIESTERASE INHIBITORS (2001-2003)
Heading Mapped to
*Pyrimidines
*Benzenesulfonamides
Frequency
133
Note
a pyrazolo-pyrimidinone similar to sildenafil; phosphodiesterase type 5 inhibitor;
Source
Arch Pharm Res 2000 Oct;23(5):471-6
J Pharm Biomed Anal. 2002 Oct 15;30(3):527-33
Date of Entry
2001/02/08
Revision Date
2023/06/22
udenafil Preferred
DA 8159 Narrower
Zidena Narrower
page delivered in 0.004s